CASP8AP2 and acute lymphoblastic leukemia: In current study, we aimed to assess the impact of the level of CASP8AP2 gene expression pre- and post-induction therapy on the outcome in pediatric ALL and to analyze its associations with early response to treatment and other prevalent prognostic factors.